[go: up one dir, main page]

PT1861713E - Método de pesquisa de marcadores de pet para monitorização precoce da terapia do cancro - Google Patents

Método de pesquisa de marcadores de pet para monitorização precoce da terapia do cancro Download PDF

Info

Publication number
PT1861713E
PT1861713E PT06727336T PT06727336T PT1861713E PT 1861713 E PT1861713 E PT 1861713E PT 06727336 T PT06727336 T PT 06727336T PT 06727336 T PT06727336 T PT 06727336T PT 1861713 E PT1861713 E PT 1861713E
Authority
PT
Portugal
Prior art keywords
cancer therapy
pet
research
early monitoring
pet tracer
Prior art date
Application number
PT06727336T
Other languages
English (en)
Inventor
Mats Bergstrom
Pasha Razifar
Azita Monnazzam
Orjan Lindhe
Raymond Awad
Bengt Langstrom
Raymond Josephsson
Carl Blomqvist
Original Assignee
Ge Healthcare Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ge Healthcare Ltd filed Critical Ge Healthcare Ltd
Publication of PT1861713E publication Critical patent/PT1861713E/pt

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5011—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing antineoplastic activity
    • G01N33/57515—

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Toxicology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Food Science & Technology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Nuclear Medicine (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
PT06727336T 2005-03-21 2006-03-20 Método de pesquisa de marcadores de pet para monitorização precoce da terapia do cancro PT1861713E (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US66381805P 2005-03-21 2005-03-21
US71972605P 2005-09-22 2005-09-22
US78226106P 2006-03-14 2006-03-14

Publications (1)

Publication Number Publication Date
PT1861713E true PT1861713E (pt) 2009-12-24

Family

ID=36727783

Family Applications (1)

Application Number Title Priority Date Filing Date
PT06727336T PT1861713E (pt) 2005-03-21 2006-03-20 Método de pesquisa de marcadores de pet para monitorização precoce da terapia do cancro

Country Status (10)

Country Link
EP (1) EP1861713B1 (pt)
AT (1) ATE443868T1 (pt)
CY (1) CY1109634T1 (pt)
DE (1) DE602006009380D1 (pt)
DK (1) DK1861713T3 (pt)
ES (1) ES2333669T3 (pt)
PL (1) PL1861713T3 (pt)
PT (1) PT1861713E (pt)
SI (1) SI1861713T1 (pt)
WO (1) WO2006100562A2 (pt)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011082191A1 (en) * 2009-12-30 2011-07-07 Ge Healthcare Limited Method of using a 99mtc-labelled injection rgd compound and a [18f]-labelled rgd injection compound in external beam radiotherapy planning
CA2964367C (en) 2014-10-14 2024-01-30 Novartis Ag Antibody molecules to pd-l1 and uses thereof
CN107847617B (zh) 2015-03-10 2021-08-31 爱默蕾大学 含有取代的亚氨基二乙酸配体的金属三羰基复合物以及作为放射性同位素示踪物的用途
WO2019106945A1 (ja) * 2017-11-28 2019-06-06 パナソニックＩｐマネジメント株式会社 培養状態判定装置、培養状態判定方法及びプログラム
US20240050047A1 (en) * 2020-12-31 2024-02-15 The Board Of Regents Of The University Of Texas System Real-time marker-less dynamic tumor tracking

Also Published As

Publication number Publication date
WO2006100562A3 (en) 2006-11-16
PL1861713T3 (pl) 2010-03-31
ES2333669T3 (es) 2010-02-25
EP1861713A2 (en) 2007-12-05
DE602006009380D1 (de) 2009-11-05
SI1861713T1 (sl) 2010-01-29
WO2006100562A2 (en) 2006-09-28
EP1861713B1 (en) 2009-09-23
DK1861713T3 (da) 2010-01-11
CY1109634T1 (el) 2014-08-13
ATE443868T1 (de) 2009-10-15

Similar Documents

Publication Publication Date Title
MX2014016036A (es) Sistemas, metodos y equipo para determinar la presencia de fluidos de interes.
WO2009072618A1 (ja) 放射線治療計画装置および放射線治療計画方法
MX343405B (es) Complejos que emiten alfa-particulas objetivo que comprenden radionuclido de torio e hidroxipiridinona que contiene ligando.
EP2074422A4 (en) METHOD AND KITS FOR DETECTING PROSTATE CANCER BIOMARKERS
GB2467467C (en) TAZ/WWTR1 for diagnosis and treatment of cancer
WO2003068054A3 (en) Identification of ovarian cancer tumor markers and therapeutic targets
MX2016012697A (es) Perfiles de marcadores biologicos de proteina para detectar tumores colorrectales.
WO2007081767A3 (en) Use of he4 and other biochemical markers for assessment of endometrial and uterine cancers
WO2012088298A3 (en) Epigenomic markers of cancer metastasis
BRPI0513896A (pt) método para a discriminação entre tecido saudável e de tumor
EP1906827A4 (en) SYSTEM AND METHOD FOR EVALUATING A DOSE ADMINISTERED BY A RADIATION THERAPY SYSTEM
EP3004394A4 (en) TESTS, METHODS AND KITS FOR ANALYZING SENSITIVITY AND RESISTANCE TO ANTICROBIAL AGENTS, PREDICTING THE PROGNOSIS OF A CANCER PATIENTS AND FOR PERSONALIZED TREATMENT STRATEGIES
WO2012154567A3 (en) Human invasion signature for prognosis of metastatic risk
WO2010009171A3 (en) Src activation for determining cancer prognosis and as a target for cancer therapy
PT1861713E (pt) Método de pesquisa de marcadores de pet para monitorização precoce da terapia do cancro
MX2012013138A (es) Metodo y sistema para tratar una formacion subterranea.
WO2021007525A3 (en) Methods and agents for the detection and treatment of cancer
WO2011051271A3 (en) Prostate tumor markers and methods of use thereof
CY1116492T1 (el) Δραστηριοτητα του τεμσιρολιμου κατα των ογκων στον καρκινο θηλοειδων νεφρικων κυτταρων
WO2011011453A3 (en) Phenotyping tumor-infiltrating leukocytes
MX2007010001A (es) Marcadores farmacogenomicos para el pronostico de tumores solidos.
TW201144806A (en) Pdia4, target of cytopiloyne derivatives, for tumor diagnosis and treatment
MX2017012182A (es) Pruebas de impacto de vehiculos.
WO2015023661A3 (en) Biomarkers for prostate cancer
EP2968922A4 (en) COMBINATION SOUND FOR LOCATING, RECORDING AND STIMULATING A TARGET WEB